Teva Pharmaceutical Industries Ltd at Citi Global Healthcare Conference Transcript
So just continuing on the third and final day of our Citi Global Healthcare conference. I'm Traver Davis, health care sector specialist at Citi, and we're delighted to have Teva with us. From the company, we have Richard Francis, President and CEO. Thanks for joining us.
Maybe to start, just hand the floor to you for a few minutes, high-level overview, current state of affairs, where you are in the growth journey. Any highlights from the third quarter that you reported about a month ago? And we'll jump into questions from there.
Great. Well, thank you for having me. Pleasure to be here. So obviously, we started on the pivot to growth strategy 3 years ago at Teva. The strategy was designed to move us from a leading generics company to a biopharma -- a world-leading biopharma company. I think we've made tremendous progress on that journey. I think there was a bit of skepticism at the start whether that was possible. But I think
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
